MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2017 International Congress

    High systolic blood pressure is associated with cognitive impairment in Parkinson’s disease (PD)

    H. Chan, Y. Cheung, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

    Objective: To assess if metabolic risk factors are associated with cognitive dysfunction in PD patients. Background: Metabolic syndrome is known as a risk factor of many…
  • 2017 International Congress

    Cognition in the PREDICT-PD Cohort

    A. Nagy, E. Hardaker, J. Bestwick, G. Giovannoni, T. Warner, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To identify whether there is evidence for cognitive dysfunction in participants identified as being at higher risk of Parkinson’s disease (PD) using the PREDICT-PD…
  • 2017 International Congress

    Classification of neurocognitive impairment in Spanish speaking Parkinson’s disease patients

    S. Anderson, C. Bermudez, N. Sun-Suslow, L. Segala, H. Moore, C. Singer, J. Jagid, G. Rey, B. Levin (Chicago, IL, USA)

    Objective: To examine differences between United States (US) and Latin American (LA) norms classifying cognitive impairment using standardized neuropsychological measures to assess cognition in Parkinson’s…
  • 2017 International Congress

    Nilotinib differentially affects oligomeric α-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson’s disease with dementia and Lewy body dementia

    F. Pagan, M. Hebron, Y. Torres-Yaghi, A. Lawler, T. Kimbason, N. Starr, B. Wilmarth, M. Arellano, A. Shekoyan, J. Ahn, C. Moussa (Washington, DC, USA)

    Objective: This is a retrospective biomarker study of an open-label clinical study to examine the safety and efficacy of lower doses (<50% of CML dose)…
  • 2017 International Congress

    Connectivity patterns in frontal cognitive regions in Parkinson’s disease

    A. Hanganu, A. Nagano-Saito, A. Tam, N. Auclair-Ouellet, S. Jobert, B. Mejia-Constain, D. Schoemaker, C. Degroot, A.-L. Lafontaine, H. Chertkow, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: Evaluate the changes in brain connectivity between Parkinson’s disease (PD) with and without mild cognitive impairment (MCI). Background: Up to 40% of PD patients…
  • 2017 International Congress

    Neuropsychiatric and Cognitive Predictors of Early Diagnosis of Progressive Supranuclear Palsy

    C. Pellicano, F. Assogna, N. Cellupica, M. Pierantozzi, A. Stefani, R. Cerroni, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)

    Objective: To define differences of neuropsychiatric and neuropsychological profile among Progressive Supranuclear Palsy (PSP) -Richardson syndrome (PSP-RS), PSP-parkinsonism (PSP-P), and Parkinson’s disease (PD), in order…
  • 2017 International Congress

    Inhibition of long term memory and induction of biochemical deficits in rats following protofibrillar Aβ 1-42 injection

    B. Nehru, S. Sharma (Chandigarh, India)

    Objective: The present study was undertaken to study the effects of single intracerebroventricular (i.c.v.) injection of protofibrillar Aβ 1-42 on the long term memory Background:…
  • 2017 International Congress

    Assessment of cognitive impairment using FP-CIT SPECT

    N. Egawa, A. Kokuryu, Y. Inoue, A. Kuzuya, R. Takahashi (Kyoto, Japan)

    Objective: We aimed to assess the cognitive impairment using FP-CIT SPECT in mild cognitive impairment or dementia patients. Background: In general, FP-CIT SPECT reflect pre-synaptic dopamine…
  • 2017 International Congress

    The Impact of Cognitive Changes on Everyday Life for People with Parkinson’s: The Patient’s Perspective

    J. Wertheimer, A. Gottuso, A. Duboille, M. Tuchman, C. Walton (Los Angeles, CA, USA)

    Objective: To understand the patient’s perspective about cognitive changes in Parkinson’s disease and about the impact of cognitive dysfunction on daily life.   Background: Cognitive dysfunction is…
  • 2017 International Congress

    Action Verbal Fluency is Related to the Functional Integrity of the Cognitive Cortico-Striatal Loop in Parkinson’s Disease

    N. Auclair-Ouellet, A. Hanganu, E. Mazerolle, J. Sarna, M. Kibreab, J. Cheetham, I. Kathol, A. Haffenden, B. Pike, O. Monchi (Calgary, AB, Canada)

    Objective: The objective of this study is to investigate the relationship between action verbal fluency (the capacity to name as many action words as possible…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley